Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (vol 397, pg 99, 2021)

Voysey, M.; Clemens, S. A. C.; Madhi, S. A.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (vol 397, pg 99, 2021)

Voysey, M.; Clemens, S. A. C.; Madhi, S. A..

Lancet ; 397(10269):98-98, 2021.

Article in English | Web of Science | ID: covidwho-1064002

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Country/Region as subject: South America / Brazil Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Country/Region as subject: South America / Brazil Language: English Journal: Lancet Year: 2021 Document Type: Article